Potent and selective RARβ
receptor agonist (Kd
values are 145 and >3760 nM for RARβ
receptors respectively; no binding detected at RARγ
). Inhibits growth of human HNSCC 22B, 183A and 22A cells (IC50
values are 3.0, 5.7 and 8.0 μ
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Clin.Cancer Res., 2000;6:1563
Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.
Mechanism of regulation and suppression of melanoma invasiveness by novel retinoic acid receptor-gamma target gene carbohydrate sulfotransferase 10.
Cancer Res., 2009;69:5218
The citations listed below are publications that use Tocris products. Selected citations for CD 2314 include:
Showing Results 1 - 2 of 2